Neurones (XPAR:NRO) COGS-to-Revenue : 0.38 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Neurones COGS-to-Revenue?

Neurones's Cost of Goods Sold for the six months ended in Dec. 2023 was €140.4 Mil. Its Revenue for the six months ended in Dec. 2023 was €372.5 Mil.

Neurones's COGS to Revenue for the six months ended in Dec. 2023 was 0.38.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Neurones's Gross Margin % for the six months ended in Dec. 2023 was 62.30%.

Neurones COGS-to-Revenue Historical Data

The historical data trend for Neurones's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones COGS-to-Revenue Chart

Neurones Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.41

0.40

0.38

Neurones Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.39	0.39	0.38	0.39	0.38

Neurones COGS-to-Revenue Calculation

Neurones's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	283.665	/	741.175
	=	0.38

Neurones's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	140.423	/	372.483
	=	0.38

Neurones (XPAR:NRO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Neurones's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	140.423 / 372.483
	=	62.30 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Neurones COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neurones's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurones (XPAR:NRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

NE9:Germany

Address

Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024

Website

https://www.neurones.net

Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.